Treatment for patients with R/R multiple myeloma should be based on the individual patient and their history, said Lisa Hwa Christenson, DNP, APRN, CNP.
Lisa Hwa Christenson, APRN, DNP, CNP, FAPO
Advertisement
Articles by Lisa Hwa Christenson, APRN, DNP, CNP, FAPO
Lisa Hwa Christenson, DNP, CNP, FAPO, shares best practices for monitoring CRS and ICANS with BCMA bispecific antibodies in community oncology.
Lisa Hwa Christenson, APRN, DNP, CNP, FAPO, outlines best practices for safely transitioning patients with multiple myeloma on bispecific antibodies to community care.
Advertisement
Latest Updated Articles
Monitoring Severe Adverse Effects of Bispecifics in Multiple MyelomaPublished: September 4th 2025 | Updated:
- Transitioning to Community Care With Multiple Myeloma
Published: August 28th 2025 | Updated:
Relapsed/Refractory Multiple Myeloma Treatment: Personalized SequencingPublished: November 3rd 2025 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
The Gift of Presence: Finding Meaning in Everyday Oncology Nursing
2
Stem Cell Transplant Nurse and NP Make Lifesaving Bone Marrow Donation
3
Proactively Managing Patients on IO Over Holiday Weekends and Beyond
4
FDA Approves Neo/Adjuvant Durvalumab Combo in Gastric/GEJ Adenocarcinoma
5
